Table of Contents

November 1989; 38 (11)

Select this article
- D Porte, Jr and
- S E Kahn
Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?
Diabetes November 1989 38:1333-1336; doi:10.2337/diabetes.38.11.1333
- Abstract
Select this article
- D J Fletcher,
- W H Rowley,
- S J Pabst,
- and J E Brinn
Age-dependent stimulation of neonatal insulin release and inositol phosphate accumulation by CCK-8 and carbachol.
Diabetes November 1989 38:1337-1342; doi:10.2337/diabetes.38.11.1337
- Abstract
Select this article
- J F Bak,
- O Schmitz,
- N S Sørensen,
- and O Pedersen
Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.
Diabetes November 1989 38:1343-1350; doi:10.2337/diabetes.38.11.1343
- Abstract
Select this article
- G E Bestetti,
- M J Reymond,
- C E Boujon,
- T Lemarchand-Béraud,
- and G L Rossi
Functional and morphological aspects of impaired TRH release by mediobasal hypothalamus of STZ-induced diabetic rats.
Diabetes November 1989 38:1351-1356; doi:10.2337/diabetes.38.11.1351
- Abstract
Select this article
- J Fowelin,
- S Attvall,
- H Von Schenck,
- U Smith,
- and I Lager
Combined effect of growth hormone and cortisol on late posthypoglycemic insulin resistance in humans.
Diabetes November 1989 38:1357-1364; doi:10.2337/diabetes.38.11.1357
- Abstract
Select this article
- D R Cornblath,
- M A Hillman,
- J S Striffler,
- C N Herman,
- and B C Hansen
Peripheral neuropathy in diabetic monkeys.
Diabetes November 1989 38:1365-1370; doi:10.2337/diabetes.38.11.1365
- Abstract
Select this article
- T P Thomas,
- T R Ellis,
- and S B Pek
Insulin release in RINm5F cells and glyceraldehyde activation of protein kinase C.
Diabetes November 1989 38:1371-1376; doi:10.2337/diabetes.38.11.1371
- Abstract
Select this article
- N Welsh,
- C Svensson,
- and M Welsh
Content of adenine nucleotide translocator mRNA in insulin-producing cells of different functional states.
Diabetes November 1989 38:1377-1380; doi:10.2337/diabetes.38.11.1377
- Abstract
Select this article
- L C Anderson,
- J R Garrett,
- A Thulin,
- and G B Proctor
Effects of streptozocin-induced diabetes on sympathetic and parasympathetic stimulation of parotid salivary gland function in rats.
Diabetes November 1989 38:1381-1389; doi:10.2337/diabetes.38.11.1381
- Abstract
Select this article
- R A Pederson,
- S Ramanadham,
- A M Buchan,
- and J H McNeill
Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Diabetes November 1989 38:1390-1395; doi:10.2337/diabetes.38.11.1390
- Abstract
Select this article
- M Peig,
- R Gomis,
- G Ercilla,
- R Casamitjana,
- G F Bottazzo,
- and R Pujol-Borrell
Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Diabetes November 1989 38:1396-1401; doi:10.2337/diabetes.38.11.1396
- Abstract
Select this article
- T Linn,
- M Noke,
- M Woehrle,
- H U Kloer,
- H P Hammes,
- D Litzlbauer,
- R G Bretzel,
- and K Federlin
Fish oil-enriched diet and reduction of low-dose streptozocin-induced hyperglycemia. Inhibition of macrophage activation.
Diabetes November 1989 38:1402-1411; doi:10.2337/diabetes.38.11.1402
- Abstract
Select this article
- E G Rillaerts,
- G J Engelmann,
- K M Van Camp,
- and I De Leeuw
Effect of omega-3 fatty acids in diet of type I diabetic subjects on lipid values and hemorheological parameters.
Diabetes November 1989 38:1412-1416; doi:10.2337/diabetes.38.11.1412
- Abstract
Select this article
- F Purrello,
- M Vetri,
- C Gatta,
- D Gullo,
- and R Vigneri
Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylation.
Diabetes November 1989 38:1417-1422; doi:10.2337/diabetes.38.11.1417
- Abstract
Select this article
- C Bogardus,
- S Lillioja,
- B L Nyomba,
- F Zurlo,
- B Swinburn,
- A Esposito-Del Puente,
- W C Knowler,
- E Ravussin,
- D M Mott,
- and P H Bennett
Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions.
Diabetes November 1989 38:1423-1432; doi:10.2337/diabetes.38.11.1423
- Abstract
Select this article
- S Fukudo,
- S Virnelli,
- C M Kuhn,
- C Cochrane,
- M N Feinglos,
- and R S Surwit
Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice.
Diabetes November 1989 38:1433-1438; doi:10.2337/diabetes.38.11.1433
- Abstract
Select this article
- E R Seaquist,
- T F Walseth,
- D M Nelson,
- and R P Robertson
Pertussis toxin-sensitive G protein mediation of PGE2 inhibition of cAMP metabolism and phasic glucose-induced insulin secretion in HIT cells.
Diabetes November 1989 38:1439-1445; doi:10.2337/diabetes.38.11.1439
- Abstract
Select this article
- M Prochazka,
- D V Serreze,
- S M Worthen,
- and E H Leiter
Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.
Diabetes November 1989 38:1446-1455; doi:10.2337/diabetes.38.11.1446
- Abstract
Select this article
- R E Maser,
- A R Steenkiste,
- J S Dorman,
- V K Nielsen,
- E B Bass,
- Q Manjoo,
- A L Drash,
- D J Becker,
- L H Kuller,
- and D A Greene
Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetes November 1989 38:1456-1461; doi:10.2337/diabetes.38.11.1456
- Abstract
Select this article
- D Faustman,
- G Eisenbarth,
- J Daley,
- and J Breitmeyer
Abnormal T-lymphocyte subsets in type I diabetes.
Diabetes November 1989 38:1462-1468; doi:10.2337/diabetes.38.11.1462
- Abstract
Select this article
- K C Wadhwani,
- L E Caspers-Velu,
- V A Murphy,
- Q R Smith,
- P F Kador,
- and S I Rapoport
Prevention of nerve edema and increased blood-nerve barrier permeability-surface area product in galactosemic rats by aldose reductase or thromboxane synthetase inhibitors.
Diabetes November 1989 38:1469-1477; doi:10.2337/diabetes.38.11.1469
- Abstract
Select this article
- F Dotta,
- P G Colman,
- D Lombardi,
- D W Scharp,
- D Andreani,
- G M Pontieri,
- U Di Mario,
- L Lenti,
- G S Eisenbarth,
- and R C Nayak
Ganglioside expression in human pancreatic islets.
Diabetes November 1989 38:1478-1483; doi:10.2337/diabetes.38.11.1478
- Abstract
Select this article
- R G Tilton,
- A Daugherty,
- S P Sutera,
- K B Larson,
- M P Land,
- D L Rateri,
- C Kilo,
- and J R Williamson
Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxan-induced diabetic rabbits.
Diabetes November 1989 38:1484-1491; doi:10.2337/diabetes.38.11.1484
- Abstract
Select this article
- A Bacelj,
- B Charlton,
- and T E Mandel
Prevention of cyclophosphamide-induced diabetes by anti-V beta 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice.
Diabetes November 1989 38:1492-1495; doi:10.2337/diabetes.38.11.1492
- Abstract
Select this article
- D E Moller,
- A Yokota,
- and J S Flier
Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM.
Diabetes November 1989 38:1496-1500; doi:10.2337/diabetes.38.11.1496
- Abstract

Current Issue

February 2012, 61 (2)

Print ISSN: 0012-1797
Online ISSN: 1939-327X

Diabetes

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

Age-dependent stimulation of neonatal insulin release and inositol phosphate accumulation by CCK-8 and carbachol.

Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.

Functional and morphological aspects of impaired TRH release by mediobasal hypothalamus of STZ-induced diabetic rats.

Combined effect of growth hormone and cortisol on late posthypoglycemic insulin resistance in humans.

Peripheral neuropathy in diabetic monkeys.

Insulin release in RINm5F cells and glyceraldehyde activation of protein kinase C.

Content of adenine nucleotide translocator mRNA in insulin-producing cells of different functional states.

Effects of streptozocin-induced diabetes on sympathetic and parasympathetic stimulation of parotid salivary gland function in rats.

Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.

Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.

Fish oil-enriched diet and reduction of low-dose streptozocin-induced hyperglycemia. Inhibition of macrophage activation.

Effect of omega-3 fatty acids in diet of type I diabetic subjects on lipid values and hemorheological parameters.

Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylation.

Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions.

Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice.

Pertussis toxin-sensitive G protein mediation of PGE2 inhibition of cAMP metabolism and phasic glucose-induced insulin secretion in HIT cells.

Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.

Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study.

Abnormal T-lymphocyte subsets in type I diabetes.

Prevention of nerve edema and increased blood-nerve barrier permeability-surface area product in galactosemic rats by aldose reductase or thromboxane synthetase inhibitors.

Ganglioside expression in human pancreatic islets.

Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxan-induced diabetic rabbits.

Prevention of cyclophosphamide-induced diabetes by anti-V beta 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice.

Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM.

This Issue

Current Issue